Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials

AbstractObjectiveTo evaluate sodium-glucose cotransporter-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists in patients with type 2 diabetes at varying cardiovascular and renal risk.DesignNetwork meta-analysis.Data sourcesMedline, Embase, and Cochrane CENTRAL up to 11 Augus...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BMJ (Online) Jg. 372; S. m4573
Hauptverfasser:	Palmer, Suetonia C, Tendal, Britta, Mustafa, Reem A, Vandvik, Per Olav, Li, Sheyu, Hao, Qiukui, Tunnicliffe, David, Ruospo, Marinella, Natale, Patrizia, Saglimbene, Valeria, Nicolucci, Antonio, Johnson, David W, Tonelli, Marcello, Rossi, Maria Chiara, Badve, Sunil V, Cho, Yeoungjee, Nadeau-Fredette, Annie-Claire, Burke, Michael, Faruque, Labib I, Lloyd, Anita, Ahmad, Nasreen, Liu, Yuanchen, Tiv, Sophanny, Millard, Tanya, Gagliardi, Lucia, Kolanu, Nithin, Barmanray, Rahul D, McMorrow, Rita, Raygoza Cortez, Ana Karina, White, Heath, Chen, Xiangyang, Zhou, Xu, Liu, Jiali, Rodríguez, Andrea Flores, González-Colmenero, Alejandro Díaz, Wang, Yang, Li, Ling, Sutanto, Surya, Solis, Ricardo Cesar, Díaz González-Colmenero, Fernando, Rodriguez-Gutierrez, René, Walsh, Michael, Guyatt, Gordon, Strippoli, Giovanni F M
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	England British Medical Journal Publishing Group 13.01.2021 BMJ Publishing Group LTD BMJ Publishing Group Ltd
Schlagworte:	Agonists Amputation Bias Blindness Body weight Cardiovascular disease Cardiovascular diseases Cardiovascular Diseases - epidemiology Cerebral infarction Clinical trials Congestive heart failure Diabetes Diabetes mellitus (non-insulin dependent) Diabetes Mellitus, Type 2 - drug therapy Diabetic neuropathy Estimates Eye diseases GLP-1 receptor agonists Glucagon Glucagon-like peptide 1 Glucagon-Like Peptide-1 Receptor Agonists Glucose Hemoglobin Humans Hypoglycemic Agents - adverse effects Hypoglycemic Agents - therapeutic use Kidney diseases Meta-analysis Mortality Myocardial infarction Patients Peptides Placebos Quality of life Randomized Controlled Trials as Topic Renal failure Renal Insufficiency - epidemiology Risk factors Sodium-glucose cotransporter Sodium-Glucose Transporter 2 Inhibitors - adverse effects Sodium-Glucose Transporter 2 Inhibitors - therapeutic use Standard deviation Systematic review
ISSN:	1756-1833, 0959-8138, 1756-1833
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!